Works matching IS 03125963 AND DT 2025 AND VI 64 AND IP 2

Results: 10

Identifying the Optimal Sampling Strategy for the Bayesian Estimation of Vancomycin AUC<sub>0–24</sub> in Adult Hematologic Cancer Patients: Bayesian Estimation of Vancomycin AUC<sub>0–24</sub> in an Adult Population with Hematologic Cancer: A. Duong et al

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 297, doi. 10.1007/s40262-025-01478-4

By:

Duong, Alexandre;
Le Blanc, Jessica;
Projean, Denis;
Marsot, Amélie

Publication type:

Article

Population Pharmacokinetic Modelling of Apixaban in End-Stage Kidney Disease Patients with Atrial Fibrillation Receiving Haemodialysis: Population Pharmacokinetics of Apixaban in Haemodialysis: C. Konecki et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 307, doi. 10.1007/s40262-025-01476-6

By:

Konecki, Celine;
Lipman, Mark L.;
Mavrakanas, Thomas A.;
Djerada, Zoubir

Publication type:

Article

Population Pharmacokinetics of Telmisartan in Healthy Subjects and Hypertensive Patients: PopPKs of Telmisartan in Healthy Subjects and Hypertensive Patients: I. H. Jeong et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 285, doi. 10.1007/s40262-024-01471-3

By:

Jeong, In Hwan;
Ryu, Sooyoon;
Han, Nayoung;
Staatz, Christine E.;
Baek, In-hwan

Publication type:

Article

Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling: Improving Understanding of Fexofenadine Pharmacokinetics: F. Gaspar et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 275, doi. 10.1007/s40262-024-01470-4

By:

Gaspar, Frédéric;
Jacost-Descombes, Celestin;
Gosselin, Pauline;
Reny, Jean-Luc;
Guidi, Monia;
Csajka, Chantal;
Samer, Caroline;
Daali, Youssef;
Terrier, Jean

Publication type:

Article

Physiologically Based Pharmacokinetic Model of Cefotaxime in Patients with Impaired Renal Function: PBPK Modeling of Cefotaxime in Patients with Kidney Disease: F. Zbib et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 257, doi. 10.1007/s40262-024-01469-x

By:

Zbib, Fatima;
Deschamps, Anthéa;
Velly, Lionel;
Blin, Olivier;
Guilhaumou, Romain;
Gattacceca, Florence

Publication type:

Article

Population Pharmacokinetics of Meropenem Across the Adult Lifespan: Population Pharmacokinetics of Meropenem: A. E. Boutzoukas et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 229, doi. 10.1007/s40262-024-01465-1

By:

Boutzoukas, Angelique E.;
Balevic, Stephen J.;
Hemmersbach-Miller, Marion;
Winokur, Patricia L.;
Gu, Kenan;
Chan, Austin W.;
Cohen-Wolkowiez, Michael;
Conrad, Thomas;
An, Guohua;
Kirkpatrick, Carl M. J.;
Swamy, Geeta K.;
Walter, Emmanuel B.;
Schmader, Kenneth E.;
Landersdorfer, Cornelia B.

Publication type:

Article

Dose Optimization of Vancomycin in Pediatric Post-Cardiac Surgery Patients: A Population Pharmacokinetic Modeling Study: Dose Optimization of Vancomycin in Pediatric Post-Cardiac Surgery Patients: J. Kamp et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 243, doi. 10.1007/s40262-024-01463-3

By:

Kamp, J.;
Wannet, D. J. E.;
Buddingh, E. P.;
van Prehn, J.;
Bunker-Wiersma, H. E.;
van Wattum, J. J.;
Klein, R. H.;
Roeleveld, P. P.;
Moes, D. J. A. R.

Publication type:

Article

Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis: Clinical Pharmacokinetics of N,N-Dimethyltryptamine: K. V. van der Heijden et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 215, doi. 10.1007/s40262-024-01450-8

By:

van der Heijden, K. V.;
Otto, M. E.;
Schoones, J. W.;
van Esdonk, M. J.;
Borghans, L. G. J. M.;
van Hasselt, J. G. C.;
van Gerven, J. M. A.;
Jacobs, G.

Publication type:

Article

All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology: Theoretical Allometry for Human Pharmacology, a Theoretical and Empirical Overview: D. W. van Valkengoed et al

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 173, doi. 10.1007/s40262-024-01444-6

By:

van Valkengoed, Daan W.;
Krekels, Elke H. J.;
Knibbe, Catherijne A. J.

Publication type:

Article

Clinical Pharmacokinetics of Antitubercular Drugs in the Overweight and Obese Population: Implications for Dosage Adjustments: Pharmacokinetics of Antitubercular Drugs in the Overweight and Obese Population: M. Prager et al.

Published in:

Clinical Pharmacokinetics, 2025, v. 64, n. 2, p. 193, doi. 10.1007/s40262-024-01442-8

By:

Prager, Marlene;
al Jalali, Valentin;
Zeitlinger, Markus

Publication type:

Article